Remaxa, enteric-coated tablets: Clinical Trials

1 trial of Remaxa, enteric-coated tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Remaxa, enteric-coated tablets: new trials by email Literature Review of Remaxa, enteric-coated tablets trials Research Report on Remaxa, enteric-coated tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
Remaxa, enteric-coated tablets, Remaxol, Placebo - Cholestasis, Intrahepatic
Phase 2 / Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company3282023-05-272025-04-29

Conditions studied

Cholestasis, Intrahepatic (1)

Sponsors

POLYSAN Scientific & Technological Pharmaceutical Company (1)

Countries

Russia (1)

Top investigators

Tatiana V Kharitonova, MD PhD (1)